Theophylline drug

Theophyllin" rel="nofollow">ine drug Order Description THEOPHYLLINE DRUG 1.Task and preparation: Written report contain" rel="nofollow">inin" rel="nofollow">ing 2000 WORDS MAXIMUM, not in" rel="nofollow">includin" rel="nofollow">ing figures, tables and reference list (which should be presented in" rel="nofollow">in VANCOUVER referencin" rel="nofollow">ing style). Students are expected to in" rel="nofollow">interpret clin" rel="nofollow">inically the case in" rel="nofollow">in an appropriate manner. Students are required to apply the appropriate pharmacokin" rel="nofollow">inetic equations/concepts in" rel="nofollow">in answerin" rel="nofollow">ing the questions. may also plot graphs and derive date from those graphs where required. 2. Presentation Present written answers to the questions as a Word document. Details should be given showin" rel="nofollow">ing the answers were derived. Hand-drawn graphs can be presented when appropriate **THE FOLLOWING TOPICS MUST BE DISCUSSED EACH IN THE BODY OF THE REPORT: (see rubric for markin" rel="nofollow">ing criteria with all these)** a) Pharmacology (mechanism of action, toxicities/adverse effects) b) Clin" rel="nofollow">inical uses c) Dosages/formulations available d) Chemical structures related to pharmacokin" rel="nofollow">inetic parameters e) Interestin" rel="nofollow">ing pharmacokin" rel="nofollow">inetic parameters (ADME, CL, Vd, k, t½…) and clin" rel="nofollow">inical implications f) Requirement for Therapeutic Drug Monitorin" rel="nofollow">ing (TDM) g) Considerations when the drug is used in" rel="nofollow">in special populations (e.g. change in" rel="nofollow">in pharmacokin" rel="nofollow">inetic parameters and dose adjustments in" rel="nofollow">in a renally or hepatically impaired patient, an overweight patient or an in" rel="nofollow">infant) **Dear writer. I will attach the detailed RUBRIC/ MARKING CRITERIA to each of the topics that you need to provide. I need you to aim the higher marks & percentage to each of the topics. These all corresponds to the topics listed above** *Markin" rel="nofollow">ing rubric (see attach detailed in" rel="nofollow">information with each of these) - Structure and Organisation (Introduction and Conclusion) 10% - Pharmacology and Formulations (a,b,c from above topics) 20% - Chemical structures related to Pharmacokin" rel="nofollow">inetic Parameters (d from above topics) 10% - Unique Pharmacokin" rel="nofollow">inetic and Requirement for Therapeutic Drug Monitorin" rel="nofollow">ing ( e & f from above topics) 20% - Drug Use in" rel="nofollow">in Special Populations ( g from above topics) 20% - Referencin" rel="nofollow">ing style and Presentation - Must be Vancouver style